71009-22-8Relevant academic research and scientific papers
Thioninium compounds and their use
-
Paragraph 0134; 0135, (2017/12/15)
This invention pertains generally to processes, uses, methods and materials utilising particular diaminophenothiazinium compounds, specifically, ETC, DEMTC, DMETC, DEETC, MTZ, ETZ, MTI, MTI.HL, ETI, ETI.HL, MTN, and ETN. These compounds are useful as drugs, for example, in the treatment of tauopathies, such as Alzheimer's disease.
INHIBITORS OF PROTEIN AGGREGATION
-
Page/Page column 46, (2008/06/13)
The invention relates generally to the use of diaminophenothiazine compounds to inhibit or reverse the aggregation of synuclein, and for their use in the manufacture of medicaments for this purpose (e.g. for the treatment of Parkinson's Disease). Also provided are related methods of detecting or labelling of aggregated synuclein.
